BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Large Growth in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 137,800 shares, an increase of 17.1% from the November 30th total of 117,700 shares. Based on an average daily volume of 120,600 shares, the days-to-cover ratio is presently 1.1 days.

BioStem Technologies Stock Down 5.2 %

OTCMKTS:BSEM traded down $0.83 during trading hours on Monday, hitting $11.99. 53,414 shares of the company’s stock traded hands, compared to its average volume of 38,395. BioStem Technologies has a 52 week low of $4.41 and a 52 week high of $28.26. The business’s fifty day simple moving average is $15.85 and its two-hundred day simple moving average is $12.09. The firm has a market cap of $199.63 million, a P/E ratio of 17.63 and a beta of -0.62.

BioStem Technologies (OTCMKTS:BSEM) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.01. The company had revenue of $82.56 million for the quarter, compared to analysts’ expectations of $78.22 million. On average, analysts expect that BioStem Technologies will post 1.41 EPS for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.